The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Billionaire hedge fund manager Bill Ackman owns just one AI stock, and it's a member of the "Magnificent Seven." ...
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT developer OpenAI ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Google agreed to a $100 million settlement over allegations of overcharging advertisers and misapplying discounts in its ...
The 4-year-old subsidiary of Google parent Alphabet said Monday that U.S. capital venture firm Thrive Capital led the funding round with participation from Google Ventures. The London-based AI ...
Isomorphic was founded in 2021 as a spin-off from Alphabet's AI research subsidiary Google Deepmind, which it acquired in 2014. U.S. drops bid to make Google sell AI investments in antitrust case ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback